X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1170) 1170
index medicus (984) 984
animals (983) 983
cancer (651) 651
chemopreventive agents (647) 647
oncology (611) 611
apoptosis (527) 527
mice (458) 458
pharmacology & pharmacy (439) 439
male (405) 405
chemopreventive agent (397) 397
resveratrol (351) 351
biochemistry & molecular biology (345) 345
female (337) 337
rats (323) 323
cell line, tumor (312) 312
curcumin (302) 302
apoptosis - drug effects (286) 286
chemoprevention (273) 273
prevention (266) 266
in-vitro (262) 262
nf-kappa-b (258) 258
oxidative stress (253) 253
stilbenes - pharmacology (234) 234
anticarcinogenic agents - pharmacology (226) 226
inhibition (224) 224
chemistry, medicinal (223) 223
carcinogenesis (202) 202
chemopreventive agent curcumin (199) 199
antineoplastic agents - pharmacology (197) 197
food science & technology (196) 196
antioxidants (183) 183
expression (183) 183
cancer chemopreventive activity (180) 180
dose-response relationship, drug (176) 176
cell proliferation - drug effects (175) 175
chemopreventive agent resveratrol (172) 172
toxicology (170) 170
analysis (167) 167
gene-expression (153) 153
cells (151) 151
curcumin - pharmacology (147) 147
metabolism (147) 147
research (144) 144
inflammation (140) 140
activation (139) 139
nutrition & dietetics (139) 139
cell survival - drug effects (138) 138
growth (137) 137
bioavailability (131) 131
trans-resveratrol (129) 129
antineoplastic agents, phytogenic - pharmacology (127) 127
antioxidants - pharmacology (127) 127
cell biology (125) 125
chemistry, multidisciplinary (125) 125
chemopreventive activity (125) 125
cell cycle (123) 123
care and treatment (122) 122
chemotherapy (120) 120
diet (120) 120
signal transduction - drug effects (119) 119
colon cancer (113) 113
in-vivo (113) 113
plant extracts - pharmacology (113) 113
tumors (113) 113
aberrant crypt foci (112) 112
health aspects (112) 112
polyphenols (108) 108
induction (107) 107
proteins (107) 107
colorectal-cancer (106) 106
neoplasms - prevention & control (106) 106
antioxidant (104) 104
cancer chemopreventive agent (104) 104
signal transduction (104) 104
cancer chemopreventive agents (102) 102
metabolites (102) 102
chemopreventive (101) 101
colorectal cancer (101) 101
neoplasms - drug therapy (101) 101
carcinogens (100) 100
breast-cancer (99) 99
enzymes (99) 99
gene expression (99) 99
molecular structure (99) 99
review (99) 99
rodents (99) 99
breast cancer (97) 97
cell cycle - drug effects (95) 95
anticarcinogenic agents - therapeutic use (94) 94
flavonoids (89) 89
medicine, research & experimental (89) 89
blotting, western (87) 87
cell line (87) 87
cytotoxicity (87) 87
proliferation (87) 87
colon-cancer (86) 86
down-regulation (83) 83
i clinical-trial (83) 83
tumor cells, cultured (83) 83
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2315) 2315
French (25) 25
Japanese (23) 23
Chinese (8) 8
German (5) 5
Russian (2) 2
Spanish (2) 2
Czech (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Seminars in Cancer Biology, ISSN 1044-579X, 2015, Volume 35, pp. S78 - S103
Journal Article
Molecules, ISSN 1420-3049, 02/2017, Volume 22, Issue 2, pp. 308 - 308
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 11/2009, Volume 61, Issue 6, pp. 842 - 846
... (6). However, this comes at a cost of additional toxicities, some of which are even fatal. The validation of a nontoxic agent that could improve on the current... 
TUMOR PROMOTION | DIETARY CURCUMIN | INDUCED COLON-CANCER | GROWTH-INHIBITION | NUTRITION & DIETETICS | ONCOLOGY | CHEMOPREVENTIVE AGENT | FACTOR-KAPPA-B | ADENOCARCINOMA CELL-LINES | I CLINICAL-TRIAL | HUMAN PANCREATIC-CANCER | ADENOMATOUS POLYPOSIS | Gastrointestinal Neoplasms - prevention & control | Gastrointestinal Neoplasms - drug therapy | Humans | Adenoma - prevention & control | Curcumin - administration & dosage | Adenoma - metabolism | Anticarcinogenic Agents - pharmacokinetics | Antineoplastic Agents, Phytogenic - administration & dosage | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Oxaliplatin | Anticarcinogenic Agents - administration & dosage | Colorectal Neoplasms - drug therapy | Gastrointestinal Neoplasms - chemically induced | Antineoplastic Agents, Phytogenic - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacokinetics | Colorectal Neoplasms - metabolism | Anticarcinogenic Agents - therapeutic use | Gastrointestinal Neoplasms - metabolism | Carcinoma - drug therapy | Curcumin - therapeutic use | Deoxycytidine - administration & dosage | Curcumin - pharmacokinetics | Treatment Outcome | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma - metabolism | Adenoma - chemically induced | Deoxycytidine - analogs & derivatives
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 02/2016, Volume 6, Issue 1, pp. 20051 - 20051
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 2017, Volume 11, pp. 103 - 121
Therapy that directly targets apoptosis and/or inflammation could be highly effective for the treatment of cancer. Murraya koenigii is an edible herb that has... 
Carbazole alkaloid | Inflammation | Chemotherapeutic | Chemopreventive | Apoptosis | CHEMISTRY, MEDICINAL | chemopreventive | ZEBRAFISH | NATURAL-PRODUCTS | MACROPHAGES | apoptosis | CARBAZOLE ALKALOIDS | carbazole alkaloid | CANCER | inflammation | chemotherapeutic | PHARMACOLOGY & PHARMACY | CELL-CYCLE | CHRONIC INFLAMMATION | NF-KAPPA-B | EXPRESSION | Apoptosis - drug effects | Humans | Alkaloids - isolation & purification | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Structure-Activity Relationship | Anti-Inflammatory Agents, Non-Steroidal - isolation & purification | Lipopolysaccharides - antagonists & inhibitors | Zebrafish - embryology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Murraya - chemistry | Dose-Response Relationship, Drug | Tumor Cells, Cultured | Cell Survival - drug effects | Nitric Oxide - biosynthesis | Alkaloids - pharmacology | Cytokines - metabolism | Nitric Oxide - antagonists & inhibitors | Antineoplastic Agents, Phytogenic - chemistry | HT29 Cells | Animals | Lipopolysaccharides - pharmacology | Cell Proliferation - drug effects | Mice | Cytokines - antagonists & inhibitors | Antineoplastic Agents, Phytogenic - pharmacology | Alkaloids - chemistry | Antineoplastic Agents, Phytogenic - isolation & purification | Drug Screening Assays, Antitumor | Antimitotic agents | Alkaloids | Composition | Pharmacology, Experimental | Rutaceae | Physiological aspects | Research | Antineoplastic agents | Health aspects | Materia medica, Vegetable | Plant extracts | Cytochrome | Bcl-2 protein | Cytotoxicity | Cancer therapies | Anticancer properties | Antioxidants | Proteins | Cyclin-dependent kinase | Mitochondria | Cell growth | Vitamin E | Condensates | Membrane potential | Inhibition | Peritonitis | Medical research | Cytokines | Iodides | Zebrafish | Leukocytes (neutrophilic) | Embryos | Acridine orange | Cytochrome c | Chemotherapy | Carbazoles | Nitric oxide | γ-Interferon | Cytochromes | Nuclei (cytology) | Carrageenan | Acridine | Bax protein | Interleukin | Colorectal cancer | Membrane permeability | Cell viability | Kinases | Colon cancer | Pretreatment | Colon | Translocation | Cell permeability | Carbazole | White blood cells | Cyclin-dependent kinase inhibitor p27 | Tumor suppressor genes | Interferon | Annexin V | Cytoplasm | Peritoneum | Tumors
Journal Article
Nutrition research reviews, ISSN 0954-4224, 06/2018, Volume 31, Issue 1, pp. 85 - 97
Despite the fact that inflammatory bowel disease (IBD) has still no recognised therapy, treatments which have proven at least mildly successful in improving... 
Inflammatory bowel disease | Inflammation | Stilbenes | Grapes | Resveratrol | (Poly)phenols | INDUCED ULCERATIVE-COLITIS | KAPPA-B ACTIVATION | INTESTINAL CACO-2 CELLS | CANCER CHEMOPREVENTIVE AGENT | NUTRITION & DIETETICS | TRANS-RESVERATROL | COLON INFLAMMATION | HEALTHY-VOLUNTEERS | SUPPRESSOR-CELLS | VITIS-VINIFERA | PHYTOALEXIN RESVERATROL | Intestinal Mucosa - metabolism | Plant Extracts - pharmacology | Humans | Polyphenols - pharmacology | Resveratrol - therapeutic use | Resveratrol - pharmacokinetics | Inflammatory Bowel Diseases - metabolism | Intestinal Absorption | Intestinal Mucosa - drug effects | Inflammation - metabolism | Inflammation - drug therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Phytotherapy | Inflammatory Bowel Diseases - drug therapy | Cytokines - metabolism | Resveratrol - pharmacology | Anti-Inflammatory Agents - pharmacology | Animals | Diet | Polyphenols - pharmacokinetics | Plant Extracts - pharmacokinetics | Polyphenols - therapeutic use | Plant Extracts - therapeutic use | Intestinal Mucosa - pathology | Wine | Animal models | Inflammatory bowel diseases | Mucosa | Colorectal cancer | Clinical trials | Biosynthesis | Drug delivery | Cancer therapies | Small intestine | Immunity | Inflammatory diseases | Fruits | Metabolites | Intestine | Bioactive compounds | Intestinal absorption | Formulations | Medical research | Antiinflammatory agents | Cytokines | Berries | Medical treatment | Metabolism | Crohns disease | Studies | Phenols | Monoclonal antibodies | In vivo methods and tests
Journal Article